Vitamin D is essential for facilitating calcium absorption and preventing increases in parathyroid hormone (PTH), which can augment bone resorption. Our objectives were to examine serum levels of 25-hydroxyvitamin D [25(OH)D] and PTH, and factors related to longitudinal change in a population-based cohort. This is the first longitudinal population-based study looking at PTH and 25(OH)D levels. We analyzed 3896 blood samples from 1896 women and 829 men in the Canadian Multicentre Osteoporosis Study over a 10-year period starting in 1995 to 1997. We fit hierarchical models with all available data and adjusted for season. Over 10 years, vitamin D supplement intake increased by 317 (95% confidence interval [CI] 277 to 359) IU/day in women and by 193 (135 to 252) IU/day in men. Serum 25(OH)D (without adjustment) increased by 9.3 (7.3 to 11.4) nmol/L in women and by 3.5 (0.6 to 6.4) nmol/L in men but increased by 4.7 (2.4 to 7.0) nmol/L in women and by 2.7 (À0.6 to 6.2) nmol/L in men after adjustment for vitamin D supplements. The percentage of participants with 25(OH)D levels <50 nmol/L was 29.7% (26.2 to 33.2) at baseline and 19.8% (18.0 to 21.6) at year 10 follow-up. PTH decreased over 10 years by 7.9 (5.4 to 11.3) pg/mL in women and by 4.6 (0.2 to 9.0) pg/mL in men. Higher 25(OH)D levels were associated with summer, younger age, lower body mass index (BMI), regular physical activity, sun exposure, and higher total calcium intake. Lower PTH levels were associated with younger age and higher 25(OH)D levels in both women and men and with lower BMI and participation in regular physical activity in women only. We have observed concurrent increasing 25(OH)D levels and decreasing PTH levels over 10 years. Secular increases in supplemental vitamin D intake influenced both changes in serum 25(OH)D and PTH levels. ß
Population-based cross-sectional studies have shown that 25(OH)D levels vary by season, (6, 7) are lower in the elderly, (8) are lower with deeper skin pigmentation, (9) are lower in obese individuals, (10) and vary by vitamin D intake. (7, 10) There are few population-based studies on temporal changes in 25(OH)D. The National Health and Nutrition Examination Surveys (NHANES) reported 25(OH)D values at different time points, although not on the same participants. Although they initially reported a decrease in 25(OH)D values, (11) most of the apparent reduction was subsequently ascribed to methodological differences. (12) The only longitudinal population-based cohort study tracked 25(OH)D over 14 years on the same participants, (13) finding that most subjects with low serum 25(OH)D levels are unlikely to have a substantial improvement in their vitamin D levels over time. PTH is believed to be an important mediator of the skeletal effects of low vitamin D status; however, the only studies assessing the association of 25(OH)D and PTH are crosssectional (8, 14, 15) or not population-based. (16) (17) (18) We therefore used the Canadian Multicentre Osteoporosis Study (CaMos) data set to examine, at the population level, longitudinal changes over time in serum levels of 25(OH)D and PTH, factors related to their change, and associations between the two.
Materials and Methods

Participants
CaMos is an ongoing, prospective cohort study of 9423 community-dwelling, randomly selected women (6539) and men (2884), aged 25 years and older at baseline, living within 50 km of nine Canadian cities (St John's, Halifax, Quebec City, Kingston, Toronto, Hamilton, Saskatoon, Calgary, and Vancouver). Baseline cohort recruitment was between 1995 and 1997. CaMos objectives, methodology, and sampling framework are described in detail elsewhere. (19) (25) that accounts for all levels of uncertainty.
For the model with PTH over time as the outcome, we also considered polynomials of 25(OH)D levels and interaction of total calcium intake with 25(OH)D levels. Separate models were run for men and women. The effects of season, vitamin D supplement, and all other possible determinants of 25(OH)D and PTH used were hypothesized not to vary with time or participants. Time was included in the models as an independent variable varying for each participant. The intercept, also varying for each participant, and the time variable were assumed to follow a normal distribution for each participant with mean mu and variance sigma. The means mu will follow their own regression lines, so that individual slopes will be allowed to vary. We used a Gibbs sampler algorithm implemented via WinBUGS software (Windows Bayesian inference Using Gibbs Sampling, Version 1.4.3 for Windows, MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK) to approximate the posterior densities of all mean and variance parameters.
Between 20,000 and 50,000 iterations in WinBUGS were run to ensure convergence of the models and used for inferences. Noninformative prior distributions have been used so that all inferences will be driven by the data. Parameter estimates and their 95% credible intervals are provided as results from these models. Credible intervals are the equivalent to confidence intervals. Descriptive analyses were performed using SAS 9.1 (Cary, NC, USA).
Results
Characteristics of the studied sample
In our study, 1313 women and 576 men had one blood measurement, 454 women and 197 men had two measurements over time, and 198 women and 77 men had three measurements. The characteristics of the study participants at each time point are presented in Table 1 . The percentage of women having their blood drawn during the summer was higher at year 10 than at baseline. Among the 4016 blood samples available, 44.6% were from Quebec City. At year 10, compared with baseline, the participants were older, had increased their sun exposure, and were more engaged in regular physical activity. Their total calcium and vitamin D intake had also increased during this period.
Calcium and vitamin D supplement intakes
The calcium and vitamin D intake from the diet stayed stable over time, and the change in total calcium and vitamin D intakes were due to an increase in supplement intakes. At baseline, 36.0% of women and 10.3% of men were taking calcium supplements for a mean (SE) calcium supplement intake in users of 487 (24) mg/day in women and 466 (110) mg/day in men. At year 10, these percentages had increased to 69.5% in women and 42.3% in men for a mean intake in users of 744 (15) mg/day in women and 494 (26) mg/day in men. At baseline, 25.6% of women and 9.2% of men were taking vitamin D supplements for a mean (SE) vitamin D supplement intake in users of 463 (122) IU/day in women and 416 (49) IU/day in men. At year 10, these percentages had increased to 68.1% in women and 41.4% in men for a mean intake in users of 755 (34) IU/day in women and 650 (69) IU/day in men. Of those using vitamin D supplements, 94.0% of women and 76.5% of men at baseline and 94.7% of women and 92.7% of men at year 10 were also taking calcium supplements. The use of calcium and vitamin D supplement by season is depicted in Fig. 1 and shows a slightly greater use in winter compared with summer.
We estimated that vitamin D supplement intake increased annually by 32 (27 to 36) IU/day in women and 19 (14 to 25) IU/day in men. Summer was associated with an estimate decrease in vitamin D supplement intake of 27 (-10 to 64) IU/day in women and 6 (-33 to 45) IU/day in men.
25(OH)D levels and change in 25(OH)D levels over time
The percentages of participants by sex, season, and year of follow-up with 25(OH)D levels <50 nmol/L and <75nmol/L are presented in Table 2 along with their 95% confidence intervals. Overall, the percentage of participants with 25(OH)D levels <50 nmol/L and <75 nmol/L had decreased by 9.9% and by 16.2%, respectively, over 10 years, with a bigger decrease in the winter compared with the summer.
Based on participants with repeated blood draws in the same season as the initial blood draw, we found that 30.5% of women and men had a 25(OH)D increase >20 nmol/L over 10 years, whereas 20.2% had a 25(OH)D decrease >20 nmol/L. These results translated into an estimated 10-year increase of 25(OH)D levels by 9.3 (7.3 to 11.4) nmol/L in women and by 3.5 (0.6 to 6.4) nmol/L in men (Table 3) 
Factors associated with longitudinal 25(OH)D levels
Factors associated with increased 25(OH)D levels included summer season, higher intake of vitamin D supplements, younger age, lower BMI, participation in regular physical activity, sun exposure, and higher total calcium intake ( Table 4) . We found different patterns of association between 25(OH)D levels and vitamin D supplement intake depending on the season and/or the sun exposure (interactions). In these multivariate models, the 10-year increases in serum 25(OH)D levels were estimated to be 4.6 (2.3 to 7.3) nmol/L in women and 3.0 (-0.7 to 6.9) nmol/L in men.
PTH levels and change in PTH levels over time Based on participants with repeated blood draws in the same season as the initial draw, we found that 31.5% of women and men had a PTH decrease >25 pg/mL over 10 years, whereas 20.7% had a PTH increase >25 pg/ml. When stratifying the participants according to their initial 25(OH)D levels (<50 nmol/L or !50 nmol/L), we found that those who had initial serum 
25(OH)D values
<50 nmol/L that later increased to !50 nmol/L had an average decrease in PTH over 10 years of 20.7 pg/mL. We estimated that PTH decreased over 10 years by 7.9 (5.4 to 11.3) pg/mL in women and by 4.6 (0.2 to 9.0) pg/mL in men. Models with a polynomial of degree three (cubic) and of second degree (quadratic) in 25(OH)D were used to explain PTH in women and men, respectively. Fig. 2 shows the relation obtained from PTH and 25(OH)D in the summer. In the winter, the curves are offset by -0.27 (-2.56 to 2.06) pg/mL in women and by -1.08 (-4.58 to 2.49) pg/mL in men. We found that the 25(OH)D levels above which PTH is no longer decreasing with increases in serum 25(OH)D were 104.2 nmol/L in women and 147.8 nmol/L in men. The 10-year declines in PTH were 5.7 (3.2 to 8.4) pg/mL in women and 3.3 (-0.7 to 7.5) pg/mL in men. Further adjusting for total calcium intake or separate models by season or by age group ( 70 or >70 years) did not change the decrease in PTH over time. The relationship between serum 25(OH)D and PTH did not change when the analysis was stratified by season. Models by age group showed a mathematical minima higher in women >70 years (118.6 nmol/L) compared with the overall model, whereas in men both models were linear and therefore not showing any stable period for PTH.
Factors associated with longitudinal PTH levels
Factors associated with lower PTH levels were higher 25(OH)D levels, younger age, and center in both women and men (Table 4 ). In women, lower PTH levels were further associated with lower BMI and participation in a regular physical activity. PTH levels were not associated with total calcium intake. In these multivariate models, the 10-year decreases in PTH levels were estimated to be 7.4 (3.9 to 10.4) pg/mL in women and 6.7 (1.5 to 11.9) pg/mL in men.
Discussion
In this population-based Canadian cohort, we found that 25(OH)D levels increased over 10 years in all age groups and in both sexes but especially in women. In contrast, NHANES had concluded that there was no change over time in the US population. (12) In the only other population-based study examining 25(OH)D over time in the same participants, Jorde and colleagues, (13) using the Tromso cohort, followed women and men aged 25 to 84 years over 14 years. They found that 43.0% of participants had 25(OH)D levels <50 nmol/L in 1994 and 40.6% in 2008, a decrease of 2.4% over 14 years. In contrast, we found in the CaMos cohort that 29.7% of participants had 25(OH)D levels <50 nmol/L in 1995 to 1997, and this had fallen to 19.8% of the population by 2005 to 2007, a decrease of 9.9% over 10 years. Those not meeting that vitamin D threshold decreased more markedly during winter but also during summer, and more markedly in women but also in men. The Canadian Health Measures Survey (CHMS) has recently reported, from a crosssectional study, prevalences of 25(OH)D levels <50 nmol/L that are similar to the CaMos year 10 results. (26) In view of the stability of the serum 25(OH)D levels in the Tromso population, Jorde and colleagues concluded that their results provided some support for the use of one single measurement of 25(OH)D to predict future health outcomes. Our results suggest that at least in our population, this might not be the case. When only those whose blood samples were drawn during the same season were used, the Tromso study also found that 20.7% of their participants had a change (increase or decrease) of more than 20 nmol/L over 14 years. In comparison, we found that 50.6% sustained a change in 25(OH)D but in 10 years, confirming a much greater rate of change in the CaMos population. Concomitant with the increase in 25(OH)D levels in our study, we observed a progressive increase in intake of vitamin D supplements over the 10 years, which was more marked in women than men and somewhat more marked in winter than summer. The higher vitamin D supplement use in winter therefore suggests that an appropriate risk mitigation strategy was being used by some participants, and this increased over the course of the study. The increase in vitamin D supplement intake might be the result of increased awareness and education of the general public about the need to consume calcium and vitamin D, but it might also be the result of increased awareness and education of participants in CaMos, a study of osteoporosis. In either case, it suggests that educational strategies directed toward increasing calcium and vitamin D intake can have a positive impact on an important approach to ameliorating osteoporosis. We also found clear increasing trends over a 10-year period in regular physical activity (a proxy for outdoor activity), sun exposure, and longitudinal trends in these factors contributing to increases in serum 25(OH)D levels. We concur with the Tromso study that season, vitamin D supplementation, BMI, and physical activity are important determinants of 25(OH)D changes over time.
An inverse relationship has been reported between PTH levels and 25(OH)D levels, (27) and we found a similar relationship in our studies. Previous studies from cross-sectional, populationbased data or from intervention studies have generally shown curvilinear relationships between 25(OH)D and PTH, with a plateau reached at various serum levels of 25(OH)D. (15, 28) One study using a convenience sample (29) and another using a population-based study (8) found an inverse relationship with no plateau. In our study, the relationship appeared similar in summer and winter for both women and men but was different between the sexes. The relationship appeared to be similar in women 70 and those >70 years old but with a PTH plateau somewhat later in the older age group. The relationship by age groups in men was similar. (31) and decreases in hip fracture rates have been reported in Canada over the past two decades. (32) Whether the lower PTH levels observed in our studies over time are relevant to the decline in hip fractures or to other aspects of bone health will, however, require further study. Undoubtedly, strengths of this study are that CaMos is a population-based longitudinal cohort comprising a recent, large sample of adults, which has collected data on an array of biological, behavioural, and environmental correlates. As well, the method of blood sample analysis ensured quality and high comparability between the different years of blood collection. Questions on sun exposure, although limited, were included to provide a relative estimate of sun-exposure rank. Household nonresponse bias related to bone health was slight, although some is still possible. (33) Another limitation is that our vitamin D intake was derived only from milk products, soya beverages, and supplements and did not include, for instance, fatty fish. However, using data from the 2004 Canadian Community Health Survey Cycle 2.2, Vatanparast and colleagues (34) reported that meat and meat alternatives (including fish) represented only 31.1% of the dietary vitamin D intake. Thus, we found that the most likely explanation for the secular increase in 25(OH)D was the increased consumption of vitamin D supplements, but we cannot preclude vitamin D contributions from nondairy sources, including fatty fish. Finally, a little less than half of the blood samples were from Quebec city; thus our results might not be representative of all centers, especially for PTH, because the center variable is associated with PTH but not with 25(OH)D in our multivariate models. Our comparisons with the CHMS in terms of 25(OH)D levels tend to show that CaMos was not biased toward having healthier people because of their long-term participation in an osteoporosis study. In summary, these results indicate a trend toward increasing 25(OH)D levels and decreasing PTH levels over 10 years. Secular increases in supplemental vitamin D have impacted both serum 25(OH)D and PTH but do not explain all of the variation in these measures.
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